| Symbol | NWBO |
|---|---|
| Name | NORTHWEST BIOTHERAPEUTICS, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 20814 United States MD 4800 Montgomery Lane Suite 800 |
| Telephone | (240) 497-9024 |
| Fax | — |
| — | |
| Website | http://www.nwbio.com |
| Incorporation | US |
| Incorporated On | 1998 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Cherry Bekaert LLP; |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001072379 |
| Description | Northwest Biotherapeutics is a biotechnology company focused on developing personalized immunotherapy products that are designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis. The Company has a broad platform technology for DCVax® dendritic cell-based vaccines. The Companys lead program involves DCVax®-L treatment for glioblastoma (GBM). Additional info from OTC: |
Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting
Read moreNorthwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform
Read moreNorthwest Biotherapeutics Announces Establishment Of the Company’s Own Dedicated Leukapheresis Clinic
Read more(99% Neutral) Northwest Biotherapeutics, Inc. (NWBO) Announces Regulatory Update
Read moreNew Form DEF 14A - NORTHWEST BIOTHERAPEUTICS INC Filed: 2025-11-28 AccNo: 0001104659-25-116966 Size: 2 MB
Read moreNew Form 424B5 - NORTHWEST BIOTHERAPEUTICS INC Filed: 2025-11-25 AccNo: 0001104659-25-116045 Size: 361 KB
Read more(99% Neutral) Northwest Biotherapeutics, Inc. (NWBO) Announces Business Combination
Read moreNorthwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility
Read moreNew Form PRE 14A - NORTHWEST BIOTHERAPEUTICS INC Filed: 2025-11-19 AccNo: 0001104659-25-114107 Size: 2 MB
Read more